文献速递前列腺癌男科与性医学

机器人辅助根治性前列腺切除术后的财务毒性及其与肿瘤学和功能结局的关系

Financial Toxicity After Robot-Assisted Radical Prostatectomy and Its Relation with Oncologic, Functional Outcomes.
PubMed 文献 · J Urol · 2022-11-01

该回顾性研究纳入2006至2021年间1,479例术前无财务毒性的机器人辅助根治性前列腺切除术患者,用欧洲癌症研究与治疗组织生活质量问卷-C30财务影响条目评估术后财务毒性。2年随访期间财务毒性发生率为8.3%(122/1379;95%CI 7.0-9.8)。财务毒性阳性组较阴性组更年轻,且临床显著的国际前列腺症状评分和尿失禁问卷简表评分升高更常见; salvage放疗率和阳性手术切缘率两组间无统计学显著差异。

要点

  • 机器人辅助根治性前列腺切除术后2年内财务毒性发生率为8.3%(122/1379;95%CI 7.0-9.8)。
  • 财务毒性阳性组较阴性组更年轻(63[58-68]岁 vs 65[61-69]岁;P=.001)。
  • 财务毒性阳性组临床显著IPSS和ICIQ-SF评分升高比例高于阴性组(34% vs 23%;62% vs 47%)。

核心结论

  • 机器人辅助根治性前列腺切除术后中期随访中财务毒性发生率低。
  • 机器人辅助根治性前列腺切除术后报告泌尿系统症状的患者也应评估财务毒性。
  • 作者建议尤其应在年轻癌症幸存者的随访中采取必要的财务毒性应对措施。

研究设计与样本

  • 回顾性纳入2006至2021年间1,479例术前评估无财务毒性的机器人辅助根治性前列腺切除术患者。
  • 财务毒性采用欧洲癌症研究与治疗组织生活质量问卷-C30财务影响条目测量,于术前及术后6、12、18、24个月收集评分。
  • 原文未报告研究机构数量及随访时间以外的设计细节。

主要发现

  • 2年随访期间任意时间点财务毒性发生率为8.3%(122/1379;95%CI 7.0-9.8)。
  • 财务毒性阳性组年龄为63[58-68]岁,显著低于财务毒性阴性组的65[61-69]岁(P=.001)。
  • 财务毒性阳性组与阴性组在挽救性放疗率(P=.8)和阳性手术切缘率(P=.2)上无统计学显著差异。
  • 财务毒性阳性组临床显著IPSS和ICIQ-SF评分升高比例分别为34%和62%,高于财务毒性阴性组的23%和47%(P=.004和P=.002)。
  • 多变量分析中,机器人辅助根治性前列腺切除术时年龄、IPSS、ICIQ-SF和生活质量评分与财务毒性相关(P<.001,OR 0.95[95%CI 0.92-0.98];P=.015,OR 2.4[95%CI 1.2-4.7];P=.032,OR 1.5[95%CI 1.2-2.5];P=.01,OR 0.09[95%CI 0.01-0.57])。

临床怎么用

  • 作者建议,机器人辅助根治性前列腺切除术后报告泌尿系统症状的患者也应评估财务毒性。
  • 作者建议,尤其应在年轻癌症幸存者的随访中采取必要的财务毒性应对措施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of the study was to evaluate frequency of financial toxicity among patients who underwent robot-assisted radical prostatectomy for prostate cancer. MATERIALS AND METHODS: Data of 1,479 robot-assisted radical prostatectomy patients between 2006-2021 reporting no financial toxicity in preoperative assessments were included retrospectively. Financial toxicity was measured with financial impact of European Organisation for Research and Treatment of Cancer-quality of life questionnaire-C30. Financial impact scores were collected preoperatively, 6, 12, 18, and 24 months after robot-assisted radical prostatectomy. RESULTS: The frequency of financial toxicity was 8.3% (122/1379; 95% CI 7.0-9.8) at any point in time throughout 2 years of follow-up. Patients reporting financial toxicity (63 [58-68]) were significantly younger than patients who had no financial toxicity (65 [61-69]; P = .001). There was no statistically significant difference between financial toxicity+ and financial toxicity- groups in terms of salvage radiotherapy (P = .8) and positive surgical margin (P = .2) rates. In functional assessments, clinically significant International Prostate Symptom Score and International Consultation on Incontinence Questionnaire-Short Form score increase of financial toxicity+ patients (34% and 62%) were more frequent than financial toxicity- patients (23% and 47%; P = .004 and P = .002, respectively). In multivariable analysis, age at robot-assisted radical prostatectomy, International Prostate Symptom Score, International Consultation on Incontinence Questionnaire-Short Form, and quality of life scores were associated with financial toxicity (P < .001, OR 0.95 [95% CI 0.92-0.98]; P = .015, OR 2.4 [95% CI 1.2-4.7]; P = .032, OR 1.5 [95% CI 1.2-2.5]; P = .01, OR 0.09 [95% CI 0.01-0.57], respectively). Patients who underwent robot-assisted radical prostatectomy before retirement (≤65 years) had a 1.6-fold increased financial toxicity risk (P = .003, 95% CI 1.1-2.3). CONCLUSIONS: Financial toxicity after robot-assisted radical prostatectomy is low in mid-term follow-up. Patients who report urological symptoms after robot-assisted radical prostatectomy should also be evaluated for financial toxicity. Required measures against financial toxicity should be taken especially in the follow-up of younger cancer survivors.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Özman O, Tillier CN, van Muilekom E, et al. Financial Toxicity After Robot-Assisted Radical Prostatectomy and Its Relation with Oncologic, Functional Outcomes. J Urol. 2022. PMID: 36205338. doi:10.1097/JU.0000000000002897

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。